Resona Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,421,836
Closed -$40.7M 836
2025
Q2
$40.7M Buy
2,421,836
+252,218
+12% +$4.45M 0.2% 103
2025
Q1
$38.4M Buy
2,169,618
+669,430
+45% +$13.4M 0.22% 98
2024
Q4
$36.4M Buy
1,500,188
+482,726
+47% +$13.8M 0.22% 88
2024
Q3
$37.8M Buy
1,017,462
+128,546
+14% +$4.79M 0.22% 90
2024
Q2
$42.2M Sell
888,916
-95,415
-10% -$4.18M 0.25% 81
2024
Q1
$37.7M Buy
+984,331
New +$32M 0.22% 92

Other funds holding STAA

Resona Asset Management's STAA Position: Q3 2025 in Review

Resona Asset Management sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 2,421,836 shares — an estimated $40.7M sold.

Resona Asset Management first reported a position in STAA in Q1 2024 and held it in 6 quarters. The position peaked at $42.2M in Q2 2024. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

  • Resona Asset Management reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
  • Resona Asset Management sold 2,421,836 STAAR Surgical shares in Q3 2025, an estimated $40.7M.
  • Resona Asset Management first reported a position in STAAR Surgical in Q1 2024 and held it in 6 quarters.
  • Resona Asset Management's STAAR Surgical position peaked at $42.2M in Q2 2024.
  • 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on Resona Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.